Publications and communications of Géraldine Piel

Bya, L.-A., Coeurderoi, A., Dinh, T. N., Bottero, B., Sacre, P.-Y., Ziemons, E., Cataldo, D., Piel, G., Lechanteur, A., & Evrard, B. (17 April 2024). Assessment of the Effects of Drying Methods on Powder Properties: A Comparative Study of Spray Drying from Solution and Suspension [Poster presentation]. 9th Workshop on Pulmonary Drug Delivery, Dublin, Ireland.

Degey, M., Berger, M., Evrard, B., & Piel, G. (10 April 2024). Exploring alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. 17th European Symposium on Controlled Drug Delivery.

Gauthy, C., Gihozo Uwera, A., Evrard, B., Malgrange, B., & Piel, G. (10 April 2024). Effect of the composition of liposomes on dexamethasone encapsulation and its kinetics of release [Poster presentation]. ESCDD Symposium 2024, Egmond aan Zee, Netherlands.

Gauthy, C., Evrard, B., Malgrange, B., & Piel, G. (19 March 2024). Optimization of liposomal formulation to achieve sustained release of dexamethasone [Poster presentation]. 14th PBP World Meeting, Vienne, Austria.

Penoy, N.* , Delma, K. L.* , Homkar, N., Karim Sakira, A., Egrek, S., Sacheli, R., Sacre, P.-Y., Grignard, B., Hayette, M.-P., Somé, T. I., Semdé, R., Evrard, B., & Piel, G. (15 February 2024). Development and optimization of a one step process for the production and sterilization of liposomes using supercritical CO2. International Journal of Pharmaceutics, 651, 123769. doi:10.1016/j.ijpharm.2024.123769

Bya, L.-A., Coeurderoi, A., Dinh, T. N., Piel, G., Lechanteur, A., & Evrard, B. (31 January 2024). STUDY OF THE IMPACT OF DRYING PROCESSES ON POWDER PROPERTIES: A COMPARATIVE ANALYSIS OF SPRAY-DRYING TECHNOLOGY FROM SOLUTION AND SUSPENSION [Paper presentation]. CIRM day 2024 - Scientific Day, Liège, Belgium.

Degey, M., Berger, M., Evrard, B., & Piel, G. (31 January 2024). New amphiphilic polymers with variable length and number of lipid chains as alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. CIRM DAY - Scientific day, Liege, Belgium.

Gauthy, C., Gihozo Uwera, A., Evrard, B., Malgrange, B., & Piel, G. (31 January 2024). Optimization of liposomal composition to efficiently encapsulate dexamethasone or dexamethasone phosphate and enable their sustained release [Poster presentation]. CIRM Day, Liège, Belgium.

Piel, G. (17 January 2024). Use of supercritical CO2 for the production and sterilization of liposomes [Paper presentation]. 1st FRITCO2T day, Liège, Belgium.

Penoy, N., Delma, K. L.* , Berger, M., Evrard, B., & Piel, G. (2024). Supercritical fluid methods for liposome production and sterilization. In Antimisiaris Sophia G., Liposomes in drug delivery : what, where, how and when to deliver. Elsevier.

Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Chain, J. L., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (2023). Poly(N-methyl‐N‐vinylacetamide): a strong alternative to PEG for lipid‐based nanocarriers delivering siRNA. Advanced Healthcare Materials, 2302712. doi:10.1002/adhm.202302712

Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Laloy, J., Pendeville-Samain, H., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (02 August 2023). Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery. Journal of Controlled Release, 361, 87 - 101. doi:10.1016/j.jconrel.2023.07.031

Piel, G. (10 July 2023). Use of supercritical CO2 for the production and sterilization of liposomes [Paper presentation]. 6th WORKSHOP OF EMJMD NANOMEDICINES FOR DRUG DELIVERY, Patras, Greece.

Tskitishvili, E., Palazzo, C., Foidart, J.-M., Piel, G., & Pequeux, C. (15 June 2023). Use of liposome-encapsulated estetrol for treatment of neonatal hypoxic-ischemic encephalopathy. Brain Research, 1809, 148369. doi:10.1016/j.brainres.2023.148369

Gallez, A., Nys, G., Wuidar, V., Dias Da Silva, I., Taziaux, M., Kinet, V., Tskitishvili, E., Noël, A., Foidart, J.-M., Piel, G., Fillet, M., & Pequeux, C. (03 June 2023). Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment. International Journal of Molecular Sciences, 24 (11), 9718. doi:10.3390/ijms24119718

Penoy, N., Delma, K. L., Grignard, B., Evrard, B., & Piel, G. (23 May 2023). The use of supercritical CO2 to develop liposomes encapsulating active pharmaceutical ingredients for pulmonary administration [Poster presentation]. 19th European Meeting on Supercritical Fluids, Budapest, Hungary.

Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (28 April 2023). LIPOSOME FOR THE TREATMENT OF COPD PRODUCED BY SUPERCRITICAL CARBON DIOXIDE-BASED TECHNOLOGIES [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (28 April 2023). Development of optimized liposomes for sustained-release transtympanic administration [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (27 April 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticle tracking method [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Penoy, N., Delma, K. L., EGREK, S., Grignard, B., Sacheli, R., Sacre, P.-Y., Hayette, M.-P., Evrard, B., & Piel, G. (27 April 2023). Supercritical CO2 to produce and sterilize liposomes: How to find supercritical parameters with the QbD strategy [Paper presentation]. BSPS - 21th Forum of Pharmaceutical Sciences, Blankerberge, Belgium.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (21 March 2023). Impact of the hydrophobic chain length of PEG derivatives on the behavior of LNPs in serum: Development of a Nanoparticle Tracking Analysis (NTA) Method [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (01 February 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticles tracking method [Paper presentation]. CIRM Day, Liege, Belgium.

Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (01 February 2023). Liposome containing ciclesonide with/without indacaterol produced by supercritical carbon dioxide-based technologies [Poster presentation]. CIRM Day, Liège, Belgium.

Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (01 February 2023). Liposome containing ciclesonide with/without indacaterol produced by supercritical carbon dioxide-based technologies [Poster presentation]. CIRM Day, Liège, Belgium.

Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (01 February 2023). Development of a sustained-release form of dexamethasone for the local treatment of sensorineural hearing loss [Poster presentation]. CIRM Day, Liège, Belgium.

Piel, G. (31 January 2023). Use of supercritical CO2 for the production and sterilization of liposomes in a one-step process [Paper presentation]. Séminaires de la faculté de Pharmacie, Paris, France.

Delma, K. L., Penoy, N., Sakira, A. K., EGREK, S., Sacheli, R., Grignard, B., Hayette, M.-P., Issa Somé, T., Evrard, B., Semdé, R., & Piel, G. (11 January 2023). Use of supercritical CO2 for the sterilization of liposomes: Study of the influence of sterilization conditions on the chemical and physical stability of phospholipids and liposomes. European Journal of Pharmaceutics and Biopharmaceutics, 183, 112 - 118. doi:10.1016/j.ejpb.2023.01.002

Bya, L.-A., Dinh, T. N., Piel, G., Lechanteur, A., & Evrard, B. (2023). Inhaled dry powder containing lipid-nanoparticles: particle engineering by spray-drying technology [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (2023). Polymer Derivative and their use as lipid nanoparticle modifiers”.

Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (2023). LIPOSOME FOR THE TREATMENT OF COPD PRODUCED BY SUPERCRITICAL CARBON DIOXIDE-BASED TECHNOLOGIES [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (15 November 2022). Amphiphilic poly(N-vinylpyrrolidone)-based lipoplex modifiers for drug delivery applications [Paper presentation]. Belgian Polymer Group (BPG) Annual Meeting, Blankenberge, Belgium.

Penoy, N., Delma, K. L., Tonakpon, H. A., Grignard, B., Evrard, B., & Piel, G. (October 2022). An innovative one step green supercritical CO2 process for the production of liposomes co-encapsulating both a hydrophobic and a hydrophilic compound for pulmonary administration. International Journal of Pharmaceutics, 627, 122212. doi:10.1016/j.ijpharm.2022.122212

Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (14 June 2022). Novel polyvinylpyrrolidone-based lipoplex modifiers for siRNA delivery [Poster presentation]. Bordeaux Polymer Conference, Bordeaux, France.

Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (01 June 2022). PNVP as PEG alternative for lipoplex modification in siRNA delivery application [Poster presentation]. Advanced Functional Polymers for Medecine (AFPM), Nice, France.

Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (30 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting), Rotterdam, Netherlands.

Delma, K. L., Delma, K. L., Penoy, N., Grignard, B., Semdé, R., Evrard, B., & Piel, G. (29 March 2022). Effects of supercritical carbon dioxide under conditions potentially conducive to sterilization on chemical stability of phospholipids and physicochemical characteristics of a liposome formulation [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Rotterdam, Netherlands.

Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (09 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 2022 Meeting of the Germany and BeNeLux & France Local Chapters of the Controlled Release Society in Aachen, Aachen, Germany.

Berger, M., Toussaint, F., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (02 February 2022). PNVP-polymers as a promising polyethyleneglycol (PEG) alternative onto anti-tumor lipoplexes surface [Paper presentation]. CIRM-Day, Liege, Belgium.

Delma, K. L., Delma, K. L., Penoy, N., Grignard, B., Semdé, R., Evrard, B., & Piel, G. (02 February 2022). Applicability of supercritical carbon dioxide sterilization to liposomes: effects of potential conditions on phospholipids and liposomes stability [Paper presentation]. CIRM day 2022, Liège, Belgium.

Delma, K. L., Penoy, N., Grignard, B., Semdé, R., Evrard, B., & Piel, G. (January 2022). Effects of supercritical carbon dioxide under conditions potentially conducive to sterilization on physicochemical characteristics of a liposome formulation containing apigenin. Journal of Supercritical Fluids, 179, 105418. doi:10.1016/j.supflu.2021.105418

Delma, K. L., Evrard, B., Piel, G., Semdé, R., & Sakira, A. K. (04 November 2021). Etude de l’applicabilité de la stérilisation par le dioxyde de carbone supercritique aux liposomes : effets de conditions opératoires sur la stabilité chimique de phospholipides [Paper presentation]. 2ème Congrès de la Société Ouest Africaine de Pharmacie Galénique et Industrielle (SOAPGI), Ouagadougou, Burkina Faso.

Ilangala Booka, A., Lechanteur, A., Fillet, M., & Piel, G. (2021). Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2021.07.010

Warnon, C., Bouhjar, K., Ninane, N., Verhoyen, M., Fattaccioli, A., Fransolet, M., Lambert de Rouvroit, C., Poumay, Y., Piel, G., Mottet, D., & Debacq-Chainiaux, F. (12 July 2021). HDAC2 and 7 down-regulation induces senescence in dermal fibroblasts. Aging, 13, 17978-18005. doi:10.18632/aging.203304

Berger, M., Lechanteur, A., Evrard, B., & Piel, G. (2021). Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: Where are we now? International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.120851

Toussaint, F., Berger, M., Sanaa, B. D., Lechanteur, A., Jérôme, C., Piel, G., Mottet, D., & Debuigne, A. (27 May 2021). Polyvinylpyrrolidone compounds as PEG alternatives for lipoplex modification [Poster presentation]. Belgian Polymer Group (BPG) Annual Meeting, remote, Belgium.

Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Debuigne, A., Mottet, D., Lechanteur, A., & Piel, G. (May 2021). Impact of amphiphilic N-vinyl pyrrolidone-based polymers used as PEG alternative on lipoplexes physico-chemical properties, cytotoxicity and gene delivery [Poster presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Piel, G. (2021). Intéret des liposomes dans le développement des compléments alimentaires.

Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (06 April 2021). Amphiphilic N-vinyl pyrrolidone-based polymers as PEG alternatives to avoid blood proteins adsorption around liposomes [Paper presentation]. Early Career Scientist Meeting 2021.

Penoy, N., Grignard, B., Evrard, B., & Piel, G. (06 April 2021). Double Encapsulation in liposomes for pulmonary administration produced by an innovative supercritical process [Paper presentation]. Controlled Release Society BeNeLux&France Early Career Scientists Meeting (online).

Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (04 March 2021). Impact of amphiphilic copolymer used as PEG alternative on the formation of a protein corona around coated-liposomes encapsulating siRNA [Paper presentation]. 2021 - Virtual Local Chapter Meeting Germany and BeNeLux & France, Aachen, Germany.

Penoy, N., Grignard, B., Evrard, B., & Piel, G. (04 March 2021). A supercritical PGSS method to encapsulate budesonide in liposome: comparison with the classical tFH method [Paper presentation]. CRS Local Chapters Meeting Germany and BeNeLux & France (online).

Penoy, N., Koch, N., Grignard, B., Evrard, B., & Piel, G. (March 2021). The quality by design strategy to prepare different liposomes formulations by a new supercritical fluid method [Poster presentation]. APGI Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Sounouvou, A. G. H. T., Defourny, C., Gbaguidi, F., Ziemons, E., Piel, G., Quetin-Leclercq, J., & Evrard, B. (01 March 2021). Development of a highly persistent silicone-based sprayable emulsion containing essential oils for treatment of skin infections. International Journal of Pharmaceutics, 596. doi:10.1016/j.ijpharm.2021.120214

Bellefroid, C., Reusch, C., Lechanteur, A., Evrard, B., Debacq-Chainiaux, Mottet, D., & Piel, G. (2021). Systematic study of liposomes composition towards efficient delivery of plasmid DNA as potential application of dermal fibroblasts targeting. International Journal of Pharmaceutics, 592, 120122. doi:10.1016/j.ijpharm.2020.120122

Delma, K. L., Lechanteur, A., Semde, R., Evrard, B., & Piel, G. (2021). Sterilization methods of liposomes: drawbacks of conventional methods and perspectives. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.120271

Penoy, N., Grignard, B., Evrard, B., & Piel, G. (2021). A supercritical fluid technology for liposome production and comparison with the film hydration method. International Journal of Pharmaceutics, 592, 120093. doi:10.1016/j.ijpharm.2020.120093

Delma, K. L., Evrard, B., Piel, G., & Semdé, R. (December 2020). Stérilisation des liposomes par le dioxyde de carbone en phase supercritique : effets des conditions sur leurs caractéristiques physicochimiques [Paper presentation]. 1er Journées Scientifiques de l’Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso.

Ledoux, A., Coelho Cristino Mamede, L. C., Palazzo, C., Furst, T., Jansen, O., De Tullio, P., Kagisha, V., Pendeville-Samain, H., Fillet, M., Piel, G., & Frederich, M. (18 May 2020). Heparin-Coated Liposomes Improve Antiplasmodial Activity and Reduce the Toxicity of Poupartone B. Planta Medica International Open, 7 (e), 73–80. doi:10.1055/a-1158-0569

Gallez, A.* , Palazzo, C.* , Blacher, S., Tskitishvili, E., Noël, A., Foidart, J.-M., Evrard, B., Pequeux, C.* , & Piel, G.*. (05 January 2020). Liposomes and drug-in-cyclodextrin-in-liposomes formulations encapsulating 17β-estradiol: an innovative drug delivery system that prevents the activation of the membrane-initiated steroid signaling (MISS) of estrogen receptor α. International Journal of Pharmaceutics, 573, 118861. doi:10.1016/j.ijpharm.2019.118861

Schmitt, C., Lechanteur, A., Cossais, F., Bellefroid, C., Arnold, P., Lucius, R., Held-Feindt, J., Piel, G., & Hattermann, K. (2020). Liposomal Encapsulated Curcumin Effectively Attenuates Neuroinflammatory and Reactive Astrogliosis Reactions in Glia Cells and Organotypic Brain Slices. International Journal of Nanomedicine, 15, 3649—3667. doi:10.2147/IJN.S245300

Bellefroid, C., Lechanteur, A., Evrard, B., Mottet, D., Debacq-Chainiaux, F., & Piel, G. (15 December 2019). In vitro skin penetration enchancement techniques: a combined approach of ethosomes and microneedles. International Journal of Pharmaceutics, 572. doi:10.1016/j.ijpharm.2019.118793

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (11 December 2019). Lipid-based nanovectors combined with microneedles to enhance skin penetration of genes: in vitro and in vivo studies [Paper presentation]. 2nd CIRM DAY, Liège, Belgium.

Delma, K. L., Semdé, R., Evrard, B., & Piel, G. (11 December 2019). Effects of supercritical carbon dioxide sterilization conditions on physicochemical characteristics of liposomes [Poster presentation]. 2nd CIRM day, Liège, Belgium.

Ilangala Booka, A., COBRAIVILLE, G., EVRARD, A., Sonveaux, Lechanteur, A., Piel, G., & Fillet, M. (11 December 2019). LC-UV as tool for nanovectorized anticancer peptide quality control: evaluation of encapsulation efficiency [Poster presentation]. 2nd Edition of CIRM day, Liege, Belgium.

Lechanteur, A., Evrard, B., & Piel, G. (11 December 2019). Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: Which critical culture parameters must be controlled? [Poster presentation]. 2nd CIRM Day.

Penoy, N., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (11 December 2019). A quality by design approach for liposomes production by innovative method using supercritical fluids: which parameters use to obtain good physicochemical characteristics? [Paper presentation]. Second CIRM Scientific Day, Liège, Belgium.

Penoy, N., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (11 December 2019). A quality by design approach for liposomes production by innovative method using supercritical fluids: which parameters use to obtain good physicochemical characteristics? [Paper presentation]. Second CIRM Scientific Day, Liège, Belgium.

Sounouvou, A. G. H. T., Toukourou, H., Lechanteur, A., Piel, G., Quetin-Leclercq, J., Gbaguidi, F., & Evrard, B. (11 December 2019). Development of dermatological dosage forms based on essential oils for the treatment of common skin infections [Paper presentation]. 2nd CIRM day, Liege, Belgium.

Sounouvou, A. G. H. T., Lechanteur, A., Quetin-Leclercq, J., Piel, G., Donneau, A.-F., Gbaguidi, F., & Evrard, B. (2019). Chromametric assessment of drug skin tolerance: A comparative study between Africans and Caucasians skins. Skin Research and Technology. doi:10.1111/srt.12804

Delma, K. L., Semdé, R., Evrard, B., & Piel, G. (27 November 2019). Etude de l’influence des conditions de stérilisation par le dioxyde de carbone en phase supercritique (CO2Sc) sur les caractéristiques physicochimiques de liposomes [Paper presentation]. 1ER CONGRES DE LA SOCIETE OUEST AFRICAINE DE PHARMACIE GALENIQUE ET INDUSTRIELLE (SOAPGI), Abidjan, Côte d’Ivoire.

Delma, K. L., Semdé, R., Evrard, B., & Piel, G. (November 2019). Etude de l’influence des conditions de stérilisation par le dioxyde de carbone en phase supercritique (CO2Sc) sur les caractéristiques physicochimiques de liposomes [Poster presentation]. Journées Scientifiques et portes ouvertes de l'Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (24 September 2019). Nucleic acids skin penetration enhancement: a combined approach of deformable liposomes and microneedles [Paper presentation]. Skin & Formulation 5th Symposium & 17th Skin Forum, Reims, France.

Lechanteur, A., Evrard, B., & Piel, G. (2019). Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: Which critical culture parameters must be controlled? European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2019.09.001

Sounouvou, A. G. H. T., Defourny, C., Quetin-Leclercq, J., Gbaguidi, F., Piel, G., & Evrard, B. (September 2019). Silicones in development of a highly persistent sprayable emulsion containing essential oils for treatment of common skin infections [Poster presentation]. Skin and Formulation 5th Symposium & 17th Skin Forum, Reims, France.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (20 May 2019). Improvement of skin penetration of lipid-based nanocarriers according to their composition [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Penoy, N., Bigazzi, W., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (20 May 2019). LIPOSOME PRODUCTION BY INNOVATIVE METHOD USING SUPERCRITICAL FLUIDS [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Sounouvou, A. G. H. T., Quetin-Leclercq, J., Piel, G., Gbaguidi, F., & Evrard, B. (20 May 2019). Assessment of drug skin tolerance in Africans using a chromameter [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Ledoux, A., Coelho Cristino Mamede, L. C., Jansen, O., Desdemoustier, P., Palazzo, C., Hamann, C., Piel, G., & Frederich, M. (17 May 2019). Natural compound-containing liposomes: a strategy for targeted activities toward artemisinin-resistant Plasmodium falciparum isolate [Poster presentation]. 4th Phytoday, Belgium.

Sounouvou, A. G. H. T., Quetin-Leclercq, J., Piel, G., & Evrard, B. (26 March 2019). Assessment of drug skin tolerance in Africans using chromameter [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (25 March 2019). Enhancement of skin penetration of lipid-based nanocarriers [Paper presentation]. 3th European Conference on Pharmaceutics, Bologne, Italy.

Bellefroid, C., Absil, G., Nikkels, A., & Piel, G. (19 February 2019). Innovative therapeutics for actinic keratosis and skin cancer [Paper presentation]. CIRM Seminairs.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (2019). Lipid gene nanocarriers for the treatment of skin diseases: current state-of-the-art. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2019.02.012

Emonts, P., Penoy, N., Rocks, N., Piel, G., Fillet, M., Hubert, P., Ziemons, E., & Evrard, B. (19 January 2019). Update of the progresses and development prospects of the FEDER project Phare [Paper presentation]. CIRM seminars, Liege, Belgium.

Bigazzi, W., Penoy, N., Evrard, B., & Piel, G. (2019). Supercritical fluid methods: an alternative to conventional methods to prepare liposomes. Chemical Engineering Journal. doi:10.1016/j.cej.2019.123106

Karim, R., Lepeltier, E., Esnaut, L., Pigeon, P., Lepinaox-Chambaud, Jaouen, G., Eyer, J., Piel, G., & Passirani, C. (2019). Surface-functionalization with NFL peptide of ferrocifen loaded lipid nanocapsules: preferential entry into human glioblastoma cells [Paper presentation]. 9th International Symposium on Bioorganometalic chemistry, York, United Kingdom.

Palazzo, C., Laloy, J., Delvigne, A. S., Nys, G., Fillet, M., Dogne, J. M., Pequeux, C., Foidart, J.-M., Evrard, B., & Piel, G. (2019). Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies. European Journal of Pharmaceutical Sciences, 9 (127), 52-59. doi:10.1016/j.ejps.2018.10.006

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (19 December 2018). Enhancement of skin penetration of lipid-based nanocarriers [Paper presentation]. 1st CIRM Scientific Day, Liège, Belgium.

Coelho Cristino Mamede, L. C., Ledoux, A., Desdemoustier, P., Jansen, O., Piel, G., Fillet, M., De Tullio, P., & Frederich, M. (19 December 2018). Quantitative analysis of a natural compound and heparin by HPLC-DAD and 1H NMR for the characterization of a liposomal formulation [Poster presentation]. The first CIRM scientific Day, Liège, Belgium.

Penoy, N., Bigazzi, W., Piel, G., & Evrard, B. (19 December 2018). Liposome production by innovative method using supercritical fluids [Paper presentation]. 1st CIRM Scientific Day, liege, Belgium.

Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (October 2018). Study of virus-like particles of human papillomavirus in CE [Paper presentation]. In the framework of High-end Foreign Experts program, Guangzhou, China.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (August 2018). Assessment of skin penetration of classical and deformable liposomes [Poster presentation]. 12th International Conference and Workshop on Biological Barriers, Saarbrücken, Germany.

Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (August 2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape [Paper presentation]. 12th International Conference and Workshop on Biological barriers, Saarbruck, Germany.

Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (13 July 2018). Strategies for the identification and quantitation of intact virus-like particles of human papillomavirus in CE [Paper presentation]. 2nd International Symposium on Advances in Pharmaceutical Analysis (APA 2018), Lille, France.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (12 July 2018). Assessment of skin penetration of classical and deformable liposomes [Paper presentation]. First NANOMED EMJMD's Workshop, Paris, France.

Piel, G. (12 July 2018). Barriers and challenges to nanomedicine developments [Paper presentation]. NANOMED EMJMD Workshop, Paris, France.

Gallez, A., Palazzo, C., Primac, I., Evrard, B., Noël, A., Piel, G., & Pequeux, C. (24 May 2018). Inclusion of 17β-estradiol into liposome : a tool to study the molecular mechanisms of estrogen receptors [Paper presentation]. 8th Meeting on Nuclear Receptors, Lyon, France.

Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. In Cationic liposomes carrying siRNA: impact of lipid composition on physicochemical properties, cytotoxicity and endosomal escape.

Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (15 March 2018). Analyse de pseudo-particules virales intactes de papillomavirus humain par électrophorèse capillaire : stratégies pour l’identification et la quantification [Paper presentation]. Analytics & Biologics : de la cellule à la petite molécule ?.

Piel, G., Lechanteur, A., & Cao, M. (17 January 2018). Update on the progresses and development prospects of the unifying theme "nanomedicine" within CIRM [Paper presentation]. CIRM seminar, Liege, Belgium.

Gallez, A., Palazzo, C., Evrard, B., Noël, A., Piel, G., & Pequeux, C. (2018). Liposomal and drug-in cyclodextrin-in-liposome formulations encapsulating 17β-estradiol prevent the activation of the non-genomic effects of estrogen receptor alpha [Paper presentation]. The 18th world congress of Gynecological Endocrinology, Florence, Italy.

Gallez, A., Palazzo, C., Evrard, B., Noël, A., Piel, G., & Pequeux, C. (2018). Inclusion of 17β-estradiol into liposome prevent the activation of membrane initiated signaling of ERalpha [Poster presentation]. EMBO Workshop/ Nuclear receptors and biological networks, Kolymbari, Greece.

Karim, R., Lepeltier, E., Esnault, L., Pigeon, P., Lemaire, L., Lépinoux-Chambaud, C., Clere, N., Jaouen, G., Piel, G., & Passirani, C. (2018). Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide. Nanoscale. doi:10.1039/c8nr02132e

Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. Nanomaterials, 8 (5). doi:10.3390/nano8050270

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (07 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. SF Nano Annual Meeting 2017, Bordeaux, France.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (05 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 4th SF Nano Annual Meeting, Bordeaux, France.

Cao, M., Karim, R., CATALDO, D., Frederich, M., Evrard, B., & Piel, G. (December 2017). Pulmonary delivery of a liposome formulation encapsulating a natural flavonoid in the treatment of lung cancer [Poster presentation]. Martine Cao, Bordeaux, France.

Karim, R., Palazzo, C., Laloy, J., Delvigne, A.-S., Vanslambrouck, S., Jérôme, C., Lepeltier, E., Orange, F., Dogne, J.-M., Evrard, B., Passirani, C., & Piel, G. (05 November 2017). Development and evaluation of injectable nanosized drug delivery systems for apigenin. International Journal of Pharmaceutics, 532 (2), 757-768. doi:10.1016/j.ijpharm.2017.04.064

Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (19 September 2017). Identification and quantitation of intact virus-like particles of human papillomavirus (HPV-VLP) using capillary electrophoresis [Paper presentation]. CE Pharm 2017.

Nys, G., Gallez, A., Kok, M., COBRAIVILLE, G., Servais, A.-C., Piel, G., Pequeux, C.* , & Fillet, M.*. (05 June 2017). Whole blood microsampling for the quantitation of estetrol without derivatization by liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 140, 258-265. doi:10.1016/j.jpba.2017.02.060

Bigazzi, W., Dufour, G., De Tullio, P., Piel, G., Cataldo, D., & Evrard, B. (June 2017). Interest of cylodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide [Poster presentation]. EuroDrying’2017 – 6th European Drying Conference, Liège, Belgium.

Lechanteur, A., Furst Tania, Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (25 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 1st SPLC-Controlled Release Society, Santiago de Compostela, Spain.

Piel, G. (2017). La nanomédecine: vers les diagnostics et traitements du futur ? [Paper presentation]. Grandes Conférences Verviétoises, Verviers, Belgium.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (04 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 2nd European Conference on Pharmaceutics: Drug Delivery, Krakow, Poland.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Piel, G., & Hubert, P. (2017). Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment. Molecular Pharmaceutics. doi:10.1021/acs.molpharmaceut.6b01154

Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (March 2017). Strategies for the identification and quantitation of virus-like particles of human papillomavirus using capillary electrophoresis [Poster presentation]. Analytical Technologies Europe 2017.

Bettonville, V., Nicol, J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (2017). Study of virus-like particles of human papillomavirus in capillary electrophoresis [Poster presentation]. 33rd International Symposium on Microscale Separations and Bioanalysis (MSB 2017), Noordwijkerhout, Netherlands.

Bettonville, V., Nicol, J. T. J., Furst, T., Thelen, N., Piel, G., Thiry, M., Fillet, M., Jacobs, N., & Servais, A.-C. (2017). Quantitation and biospecific identification of virus-like particles of human papillomavirus by capillary electrophoresis. Talanta, 175, 325-330. doi:10.1016/j.talanta.2017.07.046

Frère, A., Baroni, A., Hendrick, E., Delvigne, A. S., Orange, F., Peulen, O., Dakwar, G., Diricq, J., Dubois, P., Evrard, B., Remaut, K., Braeckmans, K., De Smedt, S., Laloy, J., Dogne, J. M., Feller, G., Mespouilles, L., Mottet, D., & Piel, G. (2017). PEGylated and Functionalized Aliphatic Polycarbonate Polyplex Nanoparticles for Intravenous Administration of HDAC5 siRNA in Cancer Therapy. ACS Applied Materials and Interfaces, 25 (9(3)), 2181-2195. doi:10.1021/acsami.6b15064

Karim, R., Lepeltier, E., Palazzo, C., Lépinoux-Chambaud, C., Evrard, B., Eyer, J., Piel, G., & Passirani, C. (2017). Enhancement of the internalization of lipid nanocapsules in human glioblastoma cells: Effect of surface concentration of NFL peptide [Poster presentation]. 11èmes Journées du Cancéropôle Grand Ouest.

Karim, R., Palazzo, C., Lepeltier, E., Lépinoux-Chambaud, C., Evrard, B., Eyer, J., Piel, G., & Passirani, C. (2017). Lipid nanocapsule internalization in U87MG human glioblastoma cells: effect of surface-functionalizing FAM-NFL.TBS-40.63 peptide concentration [Poster presentation]. 3rd CDT in Advanced Therapeutics and Nanomedicines School, 5th NanoFar School.

Karim, R., Palazzo, C., Laloy, J., Lepeltier, E., Delvigne, A.-S., Dogne, J.-M., Evrard, B., Passirani, C., & Piel, G. (December 2016). Development and comparison of liposomes and nanocapsules as injectable nanocarriers for poorly aqueous soluble drugs [Poster presentation]. Journées annuelles SFNano, Paris 2016, Paris, France.

Palazzo, C., Laloy, J., Delvigne, A.-S., Nys, G., Dogne, J.-M., Fillet, M., Foidart, J.-M., Evrard, B., & Piel, G. (December 2016). NEW INJECTABLE LIPOSOME AND DRUG-IN-CYCLODEXTRIN-IN LIPOSOME SYSTEMS ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. Journées annuelles SFNano, Paris 2016, Paris, France.

Palazzo, C., Laloy, J., Delvigne, A.-S., Nys, G., Dogne, J.-M., Karim, R., Fillet, M., Foidart, J.-M., Evrard, B., & Piel, G. (28 September 2016). INNOVATIVE INJECTABLE LIPOSOME AND DRUG-IN-CYCLODEXTRIN-IN LIPOSOME SYSTEMS ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Paper presentation]. 4th Congress on Innovation in Drug Delivery, Antibes-Juan-Les-Pins, France.

Karim, R., Palazzo, C., Laloy, J., Delvigne, A. S., Dogne, J. M., Passirani, C., Evrard, B., & Piel, G. (27 September 2016). DEVELOPMENT OF NOVEL CATIONIC AND LIGAND-GRAFTED ANIONIC LIPOSOMES FOR BRAIN-TARGETED DRUG DELIVERY [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France.

Lechanteur, A., Furst, T., Evrard, B., DELVENNE, P., Hubert, P., & Piel, G. (27 September 2016). FINDING THE RIGHT BALANCE BETWEEN EFFECTIVENESS, TOXICITY AND VAGINAL DIFFUSION OF siRNA LIPOPLEXES FOR CERVICAL CANCER TREATMENT [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France.

Furst, T., Dakwar, G., zagato, E., Lechanteur, A., Remaut, K., Evrard, B., De Smedt, S., & Piel, G. (26 September 2016). MUCOADHESIVE SPONGES WITH PEGYLATED LIPOPLEXES: TOWARDS A SUSTAINED VAGINAL DELIVERY OF siRNA [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (August 2016). PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. European Journal of Pharmaceutical Sciences, 93, 493-593. doi:10.1016/j.ejps.2016.08.058

Frère, A., Evrard, B., Mottet, D., & Piel, G. (2016). Polymeric Nanoparticles as siRNA Drug Delivery System for Cancer Therapy: The Long Road to Therapeutic Efficiency. In A. M. Holban & A. Grumezescu (Eds.), Nanoarchitectonics for Smart Delivery and Drug Targeting (pp. 503-540). Elsevier. doi:10.1016/B978-0-323-47347-7.00018-5

Furst, T., Bettonville, V., Farcas, E., Frère, A., Lechanteur, A., Evrard, B., Fillet, M., Piel, G., & Servais, A.-C. (2016). Capillary electrophoresis method to determine siRNA complexation with cationic liposomes. Electrophoresis. doi:10.1002/elps.201600249

Furst, T., Dakwar, G. R., Zagato, E., Lechanteur, A., Remaut, K., Evrard, B., Braeckmans, K., & Piel, G. (2016). Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA. Journal of Controlled Release. doi:10.1016/j.jconrel.2016.06.028

Karim, R., Palazzo, C., Evrard, B., & Piel, G. (16 February 2016). Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art. Journal of Controlled Release, 10 (227), 23-37. doi:10.1016/j.jconrel.2016.02.026

Palazzo, C., Karim, R., Evrard, B., & Piel, G. (2016). DRUG DELIVERY NANOCARRIERS TO CROSS OF THE BLOOD-BRAIN BARRIER. In A. Grumezescu (Ed.), Nanobiomaterials in drug delivery. Elsevier. doi:10.1016/B978-0-323-42866-8.00001-0

Frère, A., Baroni, A., Peulen, O., Orange, F., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (December 2015). Pegylated Polyplexes Based On HDAC5 siRNA And Aliphatic Polycarbonate Polymers For An Anticancer Therapy [Poster presentation]. European Nanomedicine Meeting, Grenoble, France.

Frère, A., Baroni, A., Peulen, O., Orange, F., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (23 November 2015). Pegylated Polyplexes Based On HDAC5 siRNA And Aliphatic Polycarbonate Polymers For An Anticancer Therapy [Poster presentation]. Biopharmacy Day, Leuven, Belgium.

Palazzo, C., Karim, R., Furst, T., Pequeux, C., Tskitishvili, E., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (25 October 2015). LIPOSOME ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, FLA, United States.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., Evrard, B., & Piel, G. (08 September 2015). Stealth Liposome and Drug-In-Cyclodextrin-In-Liposome Formulations Entrapping Apigenin as Novel Therapy for Glioblastoma [Poster presentation]. 'From drug development to target drug'- UniGR workshop on Biomedicine, Arlon, Belgium.

Piel, G. (07 September 2015). Nanomedecine: “Understanding and overcoming major barriers in cancer nanomedicine" [Paper presentation]. UniGR Workshop "Drug Development", Arlon, Belgium.

Frère, A., Tempelaar, S., Peulen, O., Evrard, B., Dubois, P., Mottet, D., & Piel, G. (September 2015). Polyplexes Based on Polycarbonate Polymers and HDAC5 siRNA Efficiently Decrease the Proliferation of Cancer Cells [Poster presentation]. UniGR biomedecine workshop, Arlon, Belgium.

Frère, A., Tempelaar, S., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (02 June 2015). Polyplex Based on Polycarbonate Polymers for an Efficient Delivery of HDAC5 and HDAC7 siRNA [Poster presentation]. Biomedica 2015, Genk, Belgium.

Palazzo, C., Karim, R., Pequeux, C., Tskitishvili, E., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (02 June 2015). Liposome Encapsulating Estetrol For The Treatment Of Ischemia Diseases In Prematures Babies [Poster presentation]. Biomedica 2015, Genk, Belgium.

Frère, A., Evrard, B., Mottet, D., & Piel, G. (28 May 2015). Polyplex Based on Polycarbonate Polymers for an Efficient Delivery of HDAC5 and HDAC7 siRNA [Paper presentation]. 18th Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (28 May 2015). DEVELOPMENT OF LIPOPLEXES FOR A TOPICAL TREATMENT OF HPV16 INDUCED LESIONS: In vitro and ex vivo studies [Paper presentation]. 18th Forum of Pharmaceutical Sciences, Blankenberg, Belgium.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (13 May 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of HPV16 induced lesions [Paper presentation]. GIGA-Cancer Day 2015, Liege, Belgium.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Piel, G. (17 April 2015). Liposomes entrapping apigenin for the treatment of glioblastoma [Poster presentation]. 2015 UKICRS Workshop & Symposium, Nottingham, United Kingdom.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Piel, G. (14 April 2015). PEGylated liposomes containing apigenin for the treatment of glioblastoma [Poster presentation]. 1st European conference on Pharmaceutics Reims 2015, Reims, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (14 April 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics Drug Delivery, Reims, France.

Palazzo, C., Karim, R., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (14 April 2015). LIPOSOME CONTAINING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. 1st European Conference on Pharmaceutics, Reims, France.

Furst, T., Lechanteur, A., Evrard, B., & Piel, G. (13 April 2015). Mucoadhesive hydroxyethyl-cellulose sponges as lipoplexes delivery system for vaginal application [Poster presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France.

Lechanteur, A.* , Furst, T.* , Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (16 February 2015). Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions. International Journal of Pharmaceutics, 483, 268-277. doi:10.1016/j.ijpharm.2015.02.041

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (11 February 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of cervical (pre)neoplastic lesions [Poster presentation]. Séminaire des chercheurs Télévie 2015, Bruxelles, Belgium.

Furst, T., Piette, M., Lechanteur, A., Evrard, B., & Piel, G. (2015). Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2015.01.019

Dufour, G., Bigazzi, W., Wong, N., Boschini, F., De Tullio, P., Piel, G., CATALDO, D., & Evrard, B. (2015). Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide. International Journal of Pharmaceutics, 495 (2), 869-878. doi:10.1016/j.ijpharm.2015.09.052

Dufour, G., Piel, G., & Evrard, B. (2015). Utilisation et caractérisation des complexes de cyclodextrines dans les formulations à usage pharmaceutique. In N. Morin-Crini, S. Fourmentin, ... G. Crini, Cyclodextrines: Histoire, propriétés, chimie et applications. Presses universitaires de Franche-Comté.

Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Hendrick, E., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (2015). Impact of the Structure of Biocompatible Aliphatic Polycarbonates on siRNA Transfection Ability. Biomacromolecules. doi:10.1021/bm501676p

Karim, R., Palazzo, C., Dubois, N., Frère, A., Bours, V., Passirani, C., Evrard, B., & Piel, G. (2015). Design of Liposomes Entrapping Apigenin- A Novel Approach for Glioblastoma Therapy [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, United States.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (2015). Anti-E6/E7/MCL-1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France.

Frère, A., Evrard, B., Mespouille, L., Mottet, D., & Piel, G. (12 December 2014). Polyplex based on polycarbonate polymers for an efficient delivery of HDAC5 and HDAC7 siRNA [Paper presentation]. Biopharmacy Day, Vlaardingen, Netherlands.

Furst, T., & Piel, G. (12 December 2014). MUCOADHESIVE HYDROXYETHYL-CELLULOSE SPONGES AS DELIVERY SYSTEM FOR VAGINAL APPLICATION [Paper presentation]. Biopharmacy Day, Vlaardingen, Netherlands.

Palazzo, C., Karim, R., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (12 December 2014). Estetrol and cyclodextrin-estetrol loaded liposomes for the treatment of ischemia diseases in premature babies [Poster presentation]. Biopharmacy Day, Vlaardingen, Netherlands.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 November 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (20 October 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 3rd NanoFar Autumn School, Louvain, Belgium.

Lechanteur, A., Furst, T., Kanber, E., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (04 October 2014). Development and optimization of pegylated lipoplexes for vaginal application [Paper presentation]. SFNano Workshop 2014, Porto, Portugal.

Frère, A., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (28 August 2014). Polyplex based on polycarbonate polymesr for an efficient delivery of an anti-angiogenic siRNA [Paper presentation]. Translational Nanomedicine, Angers, France.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (27 August 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES TO BE INCORPORATED INTO MUCOADHESIVE HEC-SPONGES [Poster presentation]. Translational Nanomedicine, International Meeting, Angers, France.

De Bleye, C., Dumont, E., Sacre, P.-Y., Chavez, P.-F., Netchacovitch, L., Piel, G., Hubert, P., & Ziemons, E. (23 June 2014). Development of a multiplexed surface-enhanced Raman scattering quantitative approach for bisphenols detection [Paper presentation]. Drug Analysis 2014, Liège, Belgium.

Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (26 May 2014). Impact of the Structure of Biocompatible Aliphatic Polycarbonate on siRNA Transfection Ability [Poster presentation]. Advanced Functional Polymers for Medicine AFPM) 2014, Liège, Belgium.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (19 May 2014). ASSOCIATION OF LIPOSOMES AND siRNA FOR A LOCAL TREATMENT OF CERVICAL CANCER [Poster presentation]. GIGA-Cancer Day 2014.

De Bleye, C., Dumont, E., Sacre, P.-Y., Chavez, P.-F., Netchacovitch, L., Piel, G., Hubert, P., & Ziemons, E. (15 May 2014). Development of an analytical method to detect simultaneously bisphenols using a multiplexed surface-enhanced Raman scattering quantitative approach [Poster presentation]. The Bioforum 2014 of BioLiège, Liège, Belgium.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 April 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES WITH siRNA ANTI E6/E7 ONCOPROTEINS FOR THE TREATMENT OF HPV CANCERS [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lisbonne, Portugal.

Frère, A., Peixoto, P., Kawalec, M., Evrard, B., Mespouille, L., Mottet, D., & Piel, G. (April 2014). Polyplexes Targeting Angiogenesis in Cancer [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceuticsand Pharmaceutical Technology, Lisbon, Portugal.

De Bleye, C.* , Sacre, P.-Y.* , Dumont, E., Netchacovitch, L., Chavez, P.-F., Piel, G., Lebrun, P., Hubert, P., & Ziemons, E. (05 March 2014). Development of a quantitative approach using surface-enhanced Raman chemical imaging: First step for the determination of an impurity in a pharmaceutical model. Journal of Pharmaceutical and Biomedical Analysis, 90, 111-118. doi:10.1016/j.jpba.2013.11.026

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (16 February 2014). Development of PEG-coated lipoplexes with siRNA anti-E6/E7 oncoproteins to be incorporated into mucoadhesive HEC-sponges for the treatment of HPV cancers [Poster presentation]. 10th International Conference and Workshop on Biological Barriers, Saarbrucken, Germany.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (16 February 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. 10th International conference and workshop on Biological Barriers.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (27 January 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. GIGA-Day 2014.

De Bleye, C., Sacre, P.-Y., Dumont, E., Chavez, P.-F., Netchacovitch, L., Piel, G., Rozet, E., Lebrun, P., Hubert, P., & Ziemons, E. (20 January 2014). Quantitative approaches based on Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Raman Chemical Imaging (SER-CI) [Paper presentation]. Forum des jeunes chercheurs, Liège, Belgium.

Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 3rd NanoFar Autumn School, Brussels, Belgium.

Frère, A., Krier, F., Evrard, B., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Piel, G. (2014). Interest of using lipid vesicular systems for dermatological applications [Paper presentation]. 2nd NANODRUG workshop, Bruxelles, Belgium.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (05 December 2013). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. Séminaire des chercheurs du Télévie 2014.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (03 December 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. 28ième Journées Scientifiques du GTRV, Angers, France.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (02 December 2013). Development of peggylated lipoplexes with siRNA anti-E6/E7 oncoproteins for the treatment og cancers induced by HPV [Poster presentation]. GTRV, Orléans, France.

Frère, A., Kawalec, M., Peixoto, P., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (December 2013). The intracellular fate of polycarbonate Polyplexes modulates the efficacy of siRNA [Poster presentation]. 28th GTRV annual meeting, Orleans, France.

De Bleye, C., Dumont, E., Rozet, E., Sacre, P.-Y., Chavez, P.-F., Netchacovitch, L., Piel, G., Hubert, P., & Ziemons, E. (15 November 2013). Determination of 4-aminophenol in a pharmaceutical formulation using Surface Enhanced Raman scattering: from development to method validation. Talanta, 116, 899-905. doi:10.1016/j.talanta.2013.07.084

De Bleye, C., Sacre, P.-Y., Dumont, E., Chavez, P.-F., Netchacovitch, L., Piel, G., Rozet, E., Lebrun, P., Hubert, P., & Ziemons, E. (17 October 2013). Development of a quantitative approach based on surface-enhanced Raman chemical imaging (SER-CI) [Paper presentation]. Belgian Society of Pharmaceutical Sciences, Spa, Belgium.

Frère, A., Peixoto, P., Mottet, D., & Piel, G. (17 October 2013). Polyplexes based on polycarbonate polymers and siRNA against HDAC7 for a targeted anti-angiogenic therapy [Paper presentation]. 17th forum of Pharmaceutical Sciences, Spa, Belgium.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 October 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. Dix-septième forum des sciences pharmaceutiques.

De Bleye, C., Sacre, P.-Y., Chavez, P.-F., Netchacovitch, L., Dumont, E., Rozet, E., Piel, G., Hubert, P., & Ziemons, E. (July 2013). Chemical imaging of small molecules from simple to complex matrices: Quantitative approaches based on Surface Enhanced Raman scattering [Paper presentation]. Symposium on Pharmaceutical and Biomedical Analysis 2013 (PBA 2013), Bologna, Italy.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 June 2013). Développement et optimisation de vecteur de type lipoplexe pour une approche thérapeutique antisens dans le cadre de lésions induites par HPV [Paper presentation]. Séminaire C.I.R.M.

Frère, A., & Piel, G. (22 April 2013). Développement de vecteurs polymériques de type polyplexes à base de nouveaux polymères cationiques biodégradables de type polycarbonates et de siRNA dirigés spécifiquement contre l’histone déacétylase 7 [Paper presentation]. Séminaire du Centre Interfacultaire de Recherche du Médicament (C.I.R.M.), Liège, Belgium.

De Bleye, C., Dumont, E., Chavez, P.-F., Netchacovitch, L., Piel, G., Rozet, E., Sacre, P.-Y., Hubert, P., & Ziemons, E. (18 April 2013). Development of quantitative approaches based on Surface Enhanced Raman Scattering chemical imaging [Poster presentation]. The bioforum 2013 of BioLiège, Liège, Belgium.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Poster presentation]. Cancer GIGA-Day 2013, liège, Belgium.

Piel, G. (2013). POLYMERIC NANOVECTORS: Actual developments and perspectives [Paper presentation]. Séminaires de Chimie, ULg.

Piel, G. (2013). Nanovecteurs polymériques et lipidiques pour le traitement du cancer: développements en cours et perspectives [Paper presentation]. Séminaires et Conférences du Louvain Drug Research Institute et de l'Ecole doctorale en sciences pharmaceutiques.

Reschner, A., Shim, Y. H., Dubois, P., Delvenne, P., Evrard, B., Marcelis, L., Moucheron, C., Kirsch-De Mesmaeker, A., Defrancq, E., Raes, M., Piette, J., Collard, L., & Piel, G. (2013). Evaluation of a new biocompatible poly(N-(morpholino ethyl methacrylate)-based copolymer for the delivery of ruthenium oligonucleotides, targeting HPV16 E6 oncogene. Journal of Biomedical Nanotechnology, 9, 1-9. doi:10.1166/jbn.2013.1634

Zime-Diawara, H., Gbaguidi, F., Semde, R., Some, I., Quetin-Leclercq, J., Moudachirou, M., Piel, G., & Evrard, B. (2013). Effect of cyclodextrins on artemisinin stability and in vitro dissolution. International Journal of Biological and Chemical Sciences, 7 (1), 356-365.

Evrard, B., & Piel, G. (2012). Le double défi de la nanomédecine [Paper presentation]. Liège Créative, Liege, Belgium.

Piel, G., & Evrard, B. (29 November 2012). Le double défi de la nanomédecine [Paper presentation]. Liègre Créative.

Lechanteur, A., Evrard, B., Delvenne, P., RONCARATI, P., Hubert, P., & Piel, G. (November 2012). Development and optimization of lipoplex vectors for an antisens therapeutic approach in the context of HPV induced lesions [Poster presentation]. Ecole doctorale en cancérologie expérimentale, liège, Belgium.

Frère, A., Kawalec, M., Collard, L., Matheus, N., Peixoto, P., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (22 October 2012). Characterization and transfection experiments of polyplexes targeting HDAC7 [Poster presentation]. NanoFar Autumn School, Angers, France.

Furst, T., Lechanteur, A., Evrard, B., Delvenne, P., Hubert, P., Piette, M., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar 1st Autumn School, Angers, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar Automn School, Angers, France.

Reschner, A., Shim, Y. H., Dubois, P., Evrard, B., DELVENNE, P., Marcelis, L., Moucheron, C., Kirsch Demmesmacher, A., Defrancq, E., Raes, M., Collard, L., & Piel, G. (2012). EVALUATION OF A NEW BIOCOMPATIBLE POLY(N-(MORPHOLINO ETHYL METHACRYLATE)-BASED COPOLYMER FOR THE DELIVERY OF Ruthenium oligonucleotides, targeting HPV16 E6 oncogene [Poster presentation]. GTRV, Paris, France.

Van Overstraeten-Schlögel, N., Shim, Y. H., Tevel, V., Piel, G., Piette, J., Dubois, P., & Raes, M. (2012). Assessment of new biocompatible Poly(N-(morpholino)ethyl methacrylate)-based copolymers by transfection of immortalized keratinoc. Drug Delivery, 16 (2), 102-111.

Zime Diawara, H., Dive, G., Piel, G., Moudachirou, M., Quetin-Leclercq, J., Frederich, M., & Evrard, B. (2012). UNDERSTANDING THE INTERACTIONS BETWEEN ARTEMISININ AND CYCLODEXTRINS: SPECTROSCOPIC STUDIES AND MOLECULAR MODELING. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 74 (1), 305-315. doi:10.1007/s10847-012-0117-9

Ducat, E., Deprez, J., Noël, A., Evrard, B., Peulen, O., & Piel, G. (06 December 2011). NUCLEAR DELIVERY OF A THERAPEUTIC PEPTIDE BY LONG CIRCULATING pH-SENSITIVE LIPOSOMES: BENEFITS OVER CLASSICAL VESICLES [Poster presentation]. XXVIth Scientific GTRV meeting, Bruxelles, Belgium.

Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (14 June 2011). Topical application of liposomes: parameters influencing their effectiveness [Poster presentation]. PharmSciFair, Prague, Czechia.

Gillet, A., Compère, P., Lecomte, F., Hubert, P., Ducat, E., Evrard, B., & Piel, G. (June 2011). Liposome surface charge influence on skin penetration behaviour. International Journal of Pharmaceutics, 411 (1-2), 223-231. doi:10.1016/j.ijpharm.2011.03.049

Piel, G. (20 May 2011). Nanotechnology based anti-cancer drug delivery systems: current developments and perspectives [Paper presentation]. GIGA cancer day 2011, Liège, Belgium.

Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (12 May 2011). Parameters influencing the skin penetration effectiveness of liposomes [Paper presentation]. 15th Forum of Pharmaceutical Sciences, Spa, Belgium.

Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (28 March 2011). Evaluation of parameters affecting skin penetration behaviour of liposomes [Poster presentation]. Skin Forum 12th Annual Meeting, Frankfurt, Germany.

Ducat, E., Deprez, J., Peulen, O., Evrard, B., & Piel, G. (25 March 2011). Peptide-loaded pH-sensitive Liposomes: effective penetration of Print3G in the nucleus of cancer cells [Paper presentation]. BIT's 4th annual protein and peptide conference, Pékin, China.

Grammenos, A., Joset, A., Leyh, B., Piel, G., & Hoebeke, M. (2011). A combination of ESR and SANS techniques to explore the cyclodextrin action on membranes. Current Medicinal Chemistry, 76.

Berton, A., Piel, G., & Evrard, B. (2011). Powdered lipid nano and microparticles : production and applications. Recent Patents on Drug Delivery and Formulation, 5 (3), 188-200. doi:10.2174/187221111797200588

Ducat, E., Deprez, J., Gillet, A., Noël, A., Evrard, B., Peulen, O.* , & Piel, G.*. (2011). Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: Benefits over classical vesicles. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2011.08.034

Ducat, E., Evrard, B., Peulen, O., & Piel, G. (2011). Cellular uptake of liposomes monitored by confocal microscopy and flow cytometry. Journal of Drug Delivery Science and Technology, 21 (6), 469-477. doi:10.1016/S1773-2247(11)50076-0

Gillet, A., Evrard, B., & Piel, G. (January 2011). Liposomes and parameters affecting their skin penetration behaviour. Journal of Drug Delivery Science and Technology, 21, 35-42. doi:10.1016/S1773-2247(11)50004-8

Gillet, A., Lecomte, F., Hubert, P., Ducat, E., Evrard, B., & Piel, G. (2011). Skin penetration behaviour of liposomes as a function of their composition. European Journal of Pharmaceutics and Biopharmaceutics, 79, 43-53. doi:10.1016/j.ejpb.2011.01.011

Piel, G., & Bochot, A. (2011). Applications of cyclodextrins for skin formulation and delivery. In E. Bilensoy (Ed.), Cyclodextrins in pharmaceutics, cosmetics and biomedicine. Wiley. doi:10.1002/9780470926819.ch9

Ducat, E., Deprez, J., Peulen, O., Evrard, B., & Piel, G. (December 2010). Cellular uptake of long-circulating pH-sensitive liposomes: evaluation of the liposome and its encapsulated material penetration in cancer cells. Drug Discovery Today, 15 (23-24), 1079-1114. doi:10.1016/j.drudis.2010.09.362

Piel, G. (29 October 2010). Traitements topiques du psoriasis [Paper presentation]. Journée Mondiale du Psoriasis, Liège, Belgium.

Ducat, E., Deprez, J., Peulen, O., Evrard, B., & Piel, G. (October 2010). PEPTIDE-LOADED LIPOSOMES AGAINST BREAST CANCER: EFFECTIVE PENETRATION IN CELLS OF LONG CIRCULATING pH-SENSITIVE VESICLES [Poster presentation]. 2nd conference on "Innovation in Drug Delivery: From Preformulation to Development through Innovative Evaluation Process", Aix-en-Provence, France.

Gillet, A., Lecomte, F., Hubert, P., Evrard, B., & Piel, G. (October 2010). Interest of vesicular systems in dermal drug delivery [Poster presentation]. 2nd Innovation in Drug Delivery, Aix-en-Provence, France.

Piel, G., Collard, L., Evrard, B., Delvenne, P., Dubois, P., & Reschner, A. (October 2010). POLYPLEXES TARGETING E6: OPTIMIZATION OF THE FORMULATIONS IN TERMS OF TRANSFECTION, TOXICITY AND EFFICIENCY [Poster presentation]. 2nd Conference Innovation in Drug Delivery: From Preformulation to development through Innovative Evaluation Process, Aix en Provence, France.

Gillet, A., Lecomte, F., Hubert, P., Evrard, B., & Piel, G. (06 July 2010). Penetration mechanism of classical and deformable liposomes through pig ear skin [Poster presentation]. Skin Forum 11th Annual Meeting, Edinburgh, United Kingdom.

Grammenos, A., Mouithys-Mickalad, A., Guelluy, P.-H., Lismont, M., Piel, G., & Hoebeke, M. (2010). ESR technique for non invasive way to quantify cyclodextrins effect on cell membranes. Biochemical and Biophysical Research Communications, 1-5. doi:10.1016/j.bbrc.2010.06.050

Ducat, E., Brion, M., Lecomte, F., Evrard, B., & Piel, G. (June 2010). The experimental design as practical approach to develop and optimize a formulation of peptide-loaded liposomes. AAPS PharmSci, 11 (2), 966-975. doi:10.1208/s12249-010-9463-3

Grammenos, A., Guelluy, P.-H., Piel, G., & Hoebeke, M. (10 May 2010). IESR spectroscopy: an easy and non invasive way to determine the extraction power of beta-Cyclodextrins on membranes [Paper presentation]. 15th International cyclodextrin symposium, Vienne, Austria.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (09 April 2010). Suggested mechanism of action of classical and deformable liposomes through pig ear skin [Paper presentation]. Perspectives in Percutaneous Penetration 2010 12th International Conference, La Grande Motte, France.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (29 March 2010). Classical and deformable liposomes: possible mechanism of penetration through pig ear skin [Poster presentation]. 8th International Conference and Workshop on Biological Barriers, Saarbrücken, Germany.

Hubert, C., Houari, S., Lecomte, F., Houbart, V., De Bleye, C., Fillet, M., Piel, G., Rozet, E., & Hubert, P. (26 January 2010). Développement et validation d'une méthode de dosage de la glucosamine par SPE/LC/MS dans le plamsa canin [Paper presentation]. Forum des jeunes chercheurs du C.I.R.M, Liège, Belgium.

Castagne, D., Dive, G., Evrard, B., Frederich, M., & Piel, G. (2010). Spectroscopic studies and molecular modeling for understanding the interactions between cholesterol and cyclodextrins. Journal of Pharmacy and Pharmaceutical Sciences, 13 (2), 362-377. doi:10.18433/j3bs34

Castagne, D., Evrard, B., Nusgens, B., & Piel, G. (2010). Effect of β-cyclodextrin and its derivatives on caveolae disruption, relationships with their cholesterol extraction capacities. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 67, 369-376. doi:10.1007/s10847-009-9718-3

Dehousse, V., Garbacki, N., Jaspart, S., Castagne, D., Piel, G., Colige, A., & Evrard, B. (2010). Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro. International Journal of Biological Macromolecules, 46, 342-349. doi:10.1016/j.ijbiomac.2010.01.010

Ducat, E., Deprez, J., Neuville, N., Peulen, O., Evrard, B., & Piel, G. (2010). Long-circulating liposomes: comparison between pH-sensitive and standard vesicles in terms of cellular uptake [Paper presentation]. 7th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, La Valette, Malta.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (2010). Suggested mechanism of action of classical and deformable liposomes through pig ear skin. Journal of Pharmacy and Pharmacology, 62 (6), 788-807.

Hubert, C., Houari, S., Lecomte, F., Houbart, V., De Bleye, C., Fillet, M., Piel, G., Rozet, E., & Hubert, P. (2010). Development and validation of a sensitive solid phase extraction/hydrophilic interaction liquid chromatography/mass spectrometry method for the accurate determination of glucosamine in dog plasma. Journal of Chromatography. A, 1217, 3275-3281. doi:10.1016/j.chroma.2010.01.024

Hubert, C., Houari, S., Lecomte, F., Houbart, V., De Bleye, C., Fillet, M., Piel, G., Rozet, E., & Hubert, P. (01 December 2009). Développement et validation d'une méthode de dosage de la glucosamine par SPE/HILIC/MS dans le plamsa de chien [Poster presentation]. 8ème congrès francophone de l'AfSep sur les sciences séparatives et les couplages, Marseille, France.

Brion, M., Jaspart, S., Perrone, L., Piel, G., & Evrard, B. (November 2009). The supercritical micronization of solid dispersions by Particles from Gas Saturated Solutions using experimental design. Journal of Supercritical Fluids, 51 (1), 50-56. doi:10.1016/j.supflu.2009.06.021

Gillet, A., Grammenos, A., Compère, P., Evrard, B., & Piel, G. (01 October 2009). Development of a new topical system: Drug-in-cyclodextrin-in-deformable liposome. International Journal of Pharmaceutics, 380 (1-2), 174-180. doi:10.1016/j.ijpharm.2009.06.027

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (09 June 2009). Betamethasone in cyclodextrin in deformable liposomes for dermal applications: ex vivo diffusion studies [Paper presentation]. PharmSciFair, Nice, France.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (07 June 2009). Betamethasone in cyclodextrin in deformable liposomes for dermal applications: ex vivo diffusion studies [Poster presentation]. PharmSciFair, Nice, France.

Castagne, D., Frederich, M., Evrard, B., Nusgens, B., Dive, G., & Piel, G. (June 2009). Studies for understanding the interactions between biological membranes and cyclodextrins and their effects at the cell level [Poster presentation]. 2nd PharmSciFair, Nice, France.

Krier, F., Riva, R., Mestdagt, M., van langendonckt, A., Jérôme, C., Piel, G., & Evrard, B. (June 2009). Development of an intraperitoneal implant for abdomino-pelvic chronic diseases [Poster presentation]. 2nd Pharmaceutical Sciences Fair and Exhibition - PharmSciFair 2009, Nice, Belgium.

Krier, F., Riva, R., Mestdagt, M., van langendonckt, A., Jérôme, C., Piel, G., & Evrard, B. (June 2009). Development of an intraperitoneal implant for abdomino-pelvic chronic diseases [Poster presentation]. Pre-Satellite Young Scientists Meeting, nice, France.

Gillet, A., Grammenos, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (14 May 2009). Betamethasone in cyclodextrin in deformable liposomes for cutaneous applications: development and diffusion studies [Paper presentation]. Quatorzième Forum des Sciences Pharmaceutiques, Blankenberge, Belgium.

Piel, G. (23 April 2009). La préparation magistrale dermatologique [Paper presentation]. Colloque de Dermatologie, Liège, Belgium.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (01 April 2009). Betamethasone in cyclodextrin in deformable liposomes for topical applications: absorption studies using pig skin [Poster presentation]. Biomedica, Liège, Belgium.

Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (09 March 2009). Development of a new cutaneous delivery system: drug in cyclodextrin in deformable liposomes [Poster presentation]. Skin and Formulation 3rd Symposium and Skin Forum 10th Annual Meeting, Versailles, France.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (09 March 2009). development and validation of a SPE-LC-UV method for the determination of betamethasone in pig skin [Poster presentation]. Skin and Formulation 3rd Symposium and Skin Forum 10th Annual Meeting, Versailles, France.

Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (03 February 2009). Mise au point de liposomes déformables contenant de la bétamethasone encapsulée sous forme de complexes dans des cyclodextrines dans le but d'une application dermatologique [Paper presentation]. Forum des Jeunes Chercheurs, Liège, Belgium.

Krier, F., Evrard, B., Piel, G., & Riva, R. (03 February 2009). Développement d'un implant intra-péritonéal contre l'endométriose [Paper presentation]. Forum des Jeunes Chercheurs du CIRM, Liège, Belgium.

Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (2009). Study of the cholesterol extraction capacity of β-cyclodextrin and its derivatives, relationships with their effects on endothelial cell viability and on membrane models. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 63 (3-4), 225-231. doi:10.1007/s10847-008-9510-9

Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). FORMULATION OF PEPTIDE-LOADED LIPOSOMES FOR INTRAVENOUS DELIVERY: OPTIMIZATION OF THE ENCAPSULATION EFFICIENCY [Paper presentation]. 14th forum of pharmaceutical sciences, Blankenberge, Belgium.

Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). CHARACTERIZATION AND OPTIMIZATION OF PEPTIDE ENCAPSULATION IN PEGYLATED LIPOSOMES [Poster presentation]. Biomedica, Liège, Belgium.

Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). CHARACTERIZATION AND OPTIMIZATION OF PEPTIDE ENCAPSULATION IN PEGYLATED LIPOSOMES [Poster presentation]. Pharmscifair, Nice, France.

Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). CARACTERISATION ET OPTIMISATION DE L’ENCAPSULATION D’UN PEPTIDE ANTAGONISTE D’ONCOPROTEINE AU SEIN DE LIPOSOMES PEGYLES [Paper presentation]. Forum des jeunes chercheurs.

Grammenos, A., Bahri, M. A., Guelluy, P.-H., Piel, G., & Hoebeke, M. (2009). Quantification of Randomly-methylated-b-cyclodextrin effect on liposome: An ESR study. Biochemical and Biophysical Research Communications, 390, 5-9. doi:10.1016/j.bbrc.2009.08.172

Grammenos, A., Guelluy, P.-H., Piel, G., & Hoebeke, M. (2009). Quantification of cholesterol extraction and microviscosity modifications involved by cyclodextrin on HCT116 cells [Poster presentation]. Biomedica, liège, Belgium.

Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (26 November 2008). Caractérisation et étude de diffusion in vitro de liposomes deformables contenant de la bétaméthasone encapsulée sous la forme de complexes dans des cyclodextrines [Poster presentation]. 11 émes Journées du Club Français des Cyclodextrines, Rouen, France.

Castagne, D., Frederich, M., Dive, G., Evrard, B., & Piel, G. (November 2008). Etude par modélisation moléculaire et spectroscopie RMN des interactions entre le cholestérol et les cyclodextrines afin de comprendre leurs effets sur les membranes cellulaires [Paper presentation]. 11èmes Journées du Club français des Cyclodextrines, Rouen, France.

Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (10 October 2008). Betamethasone in cyclodextrin in deformable liposomes, a new cutaneous delivery system: characterization and in vitro diffusion studies [Paper presentation]. European IP-Galenos Course- Skin barrier Function: Cutaneous absoprtion and environmental factors, Lyon, France.

Grammenos, A., Bahri, M. A., Piel, G., & Hoebeke, M. (16 May 2008). Impact of a cyclodextrin on liposome sans cells : ESR evidence [Poster presentation]. Sixteenth Meeting of the Benelux EPR Group, Gent, Belgium.

Grammenos, A., Leyh, B., Piel, G., Bahri, M. A., & Hoebeke, M. (09 May 2008). Impact of randomly-methylated-beta- cyclodextrin on DMPC liposomes and cell [Paper presentation]. 14th International cyclodextrin symposium, Kyoto, Japan.

Castagne, D., Blacher, S., Alvarez Gonzalez, M.-L., Berndt, S., Piette, M., Evrard, B., Nusgens, B., Noël, A., & Piel, G. (May 2008). Effect of b-cyclodextrin and its methylated derivatives on the ex-vivo rat aortic ring angiogenesis assay [Poster presentation]. XIIth BELACT Meeting, Namur, Belgium.

Castagne, D., Fillet, M., Evrard, B., Nusgens, B., & Piel, G. (April 2008). Determination of the ideal cyclodextrin concentrations to study their effect in the lipid rafts by the use of cholesterol extraction and cell viability studies in endothelial cells [Poster presentation]. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona, Spain.

Barillaro, V., Dive, G., Ziemons, E., Bertholet, P., Evrard, B., Delattre, L., & Piel, G. (10 February 2008). Theoretical and Experimental Vibrational Study of Miconazole and Its Dimers with Organic Acids: Application to the IR Characterization of Its Inclusion Complexes with Cyclodextrins. International Journal of Pharmaceutics, 350 (1-2), 155-165. doi:10.1016/j.ijpharm.2007.08.048

Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Frederich, M., Ziemons, E., & Piel, G. (22 January 2008). Theoretical and Experimental Investigations of Organic Acids/Cyclodextrin Complexes and Their Consequences Upon the Formation of Miconazole/Cyclodextrin/Acid Ternary Inclusion Complexes. International Journal of Pharmaceutics, 347 (1-2), 62-70. doi:10.1016/j.ijpharm.2007.06.030

Ducat, E., Evrard, B., & Piel, G. (2008). STUDY OF PEGYLATED LIPOSOMES CRYOPROTECTION IN TERMS OF RETENTION EFFICIENCY [Poster presentation]. 6th international workshop on drug delivery systems for nanomedecines, Liblice, Czechia.

Krier, F., Nizet, D., Riva, R., Mestdagt, M., Frankenne, F., Jérôme, C., Piel, G., & Evrard, B. (2008). DEVELOPMENT OF AN INTRAPERITONEAL IMPLANT FOR THE ENDOMETRIOSIS TREATMENT [Poster presentation]. 6th World Meeting on Pharmaceutics, biopharmaceutics and pharmaceutical technology, Barcelone, Spain.

Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (November 2007). Interaction de la b-cyclodextrine et de ses dérivés avec des cellules endothéliales: dosage du cholestérol résiduel [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France.

Grammenos, A., Leyh, B., Joset, A., Piel, G., Bahri, M. A., & Hoebeke, M. (November 2007). Etude de la Rameb par resonance paramagnétique électronique et diffusion de neutrons aux petits angles [Paper presentation]. 10ème journée du club français des cyclodextrines, Lens, France.

Castagne, D., Delattre, L., Evrard, B., Fillet, M., Nusgens, B., & Piel, G. (October 2007). Cell membrane destructuration using cyclodextrins: effect on cholesterol content of endothelial cells [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (October 2007). Characterization of siRNA lipoplexes in terms of size and zeta potential data [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy.

Piel, G., Ducat, E., Grammenos, A., Evrard, B., & Delattre, L. (October 2007). Encapsulation of betamethasone-HP-gCD complex in deformable liposomes [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy.

Grammenos, A., Piel, G., Bahri, M. A., & Hoebeke, M. (September 2007). Electron spin resonance study: the drug impact on membrane viscosity [Poster presentation]. 12th European Conference on the Spectroscopy of Biological Molecules, Bobigny, France.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (29 June 2007). Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. International Journal of Pharmaceutics, 338 (1-2), 35-42. doi:10.1016/j.ijpharm.2007.01.015

Tursilli, R., Piel, G., Delattre, L., & Scalia, S. (June 2007). Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: Effect of the vehicle. European Journal of Pharmaceutics and Biopharmaceutics, 66 (3), 483-487. doi:10.1016/j.ejpb.2007.02.017

Castagne, D., Belhadj Salem, L., Delattre, L., Nusgens, B., & Piel, G. (April 2007). Evaluation of the cytotoxicity of cyclodextrins on endothelial cells using MTT assay [Poster presentation]. Pharmaceutical Sciences World Congress, Amsterdam, Netherlands.

Grammenos, A., Bahri, M. A., Piel, G., Votion, D., & Hoebeke, M. (April 2007). Electron Spin Resonance study : The impact of food or drug on membrane viscosity [Poster presentation]. Biomedica.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (April 2007). Study of the interaction between cyclodextrins and liposome membranes: effect on the permeability of liposomes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 309-311. doi:10.1007/s10847-006-9178-y

Piette, M., Castagne, D., Delattre, L., & Piel, G. (April 2007). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 101-103. doi:10.1007/s10847-006-9214-y

Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Ziemons, E., & Piel, G. (2007). Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: Molecular modeling studies. International Journal of Pharmaceutics, 342 (1-2), 152-160. doi:10.1016/j.ijpharm.2007.05.003

Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimization of drug-cyclodextrin complexation reaction by a static supercritical carbon dioxide method [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimisation de la réaction de complexation entre une cyclodextrine et un composé pharmaceutique par utilisation du CO2 supercritque [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France.

Castagne, D., Belhadj Salem, L., Delattre, L., Nusgens, B., & Piel, G. (2007). Effect of cyclodextrins on the viability of endothelial cells. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 105-107. doi:10.1007/s10847-006-9211-1

Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (2007). Studies on the structure of cationic liposomes/siRNA complexes by zeta potential and size measurement [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Evrard, B., Bertholet, P., Guéders, M., Piette, M., Piel, G., Cataldo, D., & Delattre, L. (2007). Contribution of cyclodextrins in the developement of different pharmaceutical formulations of a nex matrix metalloproteinase inhibitor. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 57 (1-4), 303-308. doi:10.1007/s10847-006-9177-z

Grammenos, A., Leyh, B., Joset, A., Piel, G., Bahri, M. A., & Hoebeke, M. (2007). Etude de la Rameb par résonance paramagnétique électronique (RPE) et diffusion de neutrons aux petits angles (SANS) [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France.

Jaspart, S., Bertholet, P., Piel, G., Dogné, J.-M., Delattre, L., & Evrard, B. (January 2007). Solid lipid microparticles as a sustained release system for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics, 65 (1), 47-56. doi:10.1016/j.ejpb.2006.07.006

Krier, F., Nizet, D., Riva, R., colombo, M., Frankenne, F., Jérôme, C., Piel, G., Delattre, L., & Evrard, B. (2007). DEVELOPMENT OF AN INTRAPERITONEAL IMPLANT FOR THE ENDOMETRIOSIS TREATMENT [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Nizet, D., Jaspart, S., Brion, M., Piel, G., Delattre, L., & Evrard, B. (2007). Supercritical fluid technology to produce solid lipid microparticles [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Piel, G., Coia, I., Uhoda, E., Pierard, G., Evrard, B., & Delattre, L. (October 2006). Assessment of betamethasone-in-cyclodextrin-in-liposome induced skin blanching response [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European Journal of Pharmaceutical Sciences, 28 (3), 189-195. doi:10.1016/j.ejps.2006.01.011

Piette, M., Castagne, D., Delattre, L., & Piel, G. (May 2006). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes [Poster presentation]. 13th International Cyclodextrin Symposium, Turin, Italy.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (07 April 2006). Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics. International Journal of Pharmaceutics, 312 (1-2), 75-82. doi:10.1016/j.ijpharm.2005.12.044

Barillaro, V., Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (2006). Application of supercritical carbon dioxide to the preparation of inclusion complexes into cyclodextrins [Paper presentation]. 13th International Pharmaceutical Technology Symposium, Antalya, Turkey.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (2006). Study of the interaction between cyclodextrins and liposomes membranes: effect on the permeability of liposomes [Paper presentation]. XIII th International Cyclodextrin Symposium, Torino, Italy.

Tursilli, R., Scalia, S., Piel, G., Jaspart, S., & Delattre, L. (2006). Encapsulation of the sunscreen agent, octyl dimethyl PABA, in lipid microparticles: effect on photostability [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (November 2005). Effect of cyclodextrins on the membrane permeability of liposomes [Poster presentation]. 2nd EUFEPS conference on optimising drug delivery and formulation, Versailles, France.

Barillaro, V., Bertholet, P., Evrard, B., Delattre, L., Dive, G., & Piel, G. (September 2005). Inclusion of miconazole into cyclodextrins by means of supercritical carbon dioxide: effect of acidic ternary compound and molecular modelling study [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy.

Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (September 2005). Encapsulation of betamethasone-cyclodextrin inclusion complexes in liposmes: effect of cyclodextrins on the encapsulation efficinecy and the kinetic release of betamethasone [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy.

Bertholet, P., Jaspart, S., Bodson, C., Piette, M., Piel, G., Delattre, L., & Evrard, B. (June 2005). The effect of cyclodextrins on the aqueous solubility of a new MMP inhihbitor: phase solubility, 1H-NMR spectroscopy and molecular modelling studies, preparation and stability study of nebulizable solutions [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France.

Piel, G., Boulmedarat, L., Bochot, A., Lesieur, S., Delattre, L., & Fattal, E. (June 2005). Cyclodextrin-mediated drug release from liposomes dispersed within a bioadhesive gel. Pharmaceutical Research, 22 (6), 962-971. doi:10.1007/s11095-005-4591-2

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2005). Pharmacokinetic study of a new syntheyic MMP inhibitor (Ro 28-2653) after IV and oral administration of solutions containing hydroxypropyl-b-cyclodextrin [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France.

Chiap, P., Piette, M., Evrard, B., Frankenne, F., Christiaens, B., Piel, G., Cataldo, D., Foidart, J.-M., Delattre, L., Crommen, J., & Hubert, P. (05 March 2005). Automated method for the determination of a new matrix metalloproteinase inhibitor in ovine plasma and serum by coupling of restricted access material for on-line sample clean-up to liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817 (1), 109-117. doi:10.1016/j.jchromb.2004.08.042

Bahri, M. A., Hambach, L., Piel, G., Seret, A., & Hoebeke, M. (March 2005). ESR quantification of liposome membrane microviscosity change induced by the addition of cholesterol and drugs [Poster presentation]. 38th Annual International Meeting of the Electron Spin Resonance Group of the Royal Society of Chemistry, Advanced Techniques and Applications of EPR, Bath, United Kingdom.

Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (March 2005). Influence des cyclodextrines sur la vitesse de libération de la bétamethasone encapsulée sous forme de complexe dans des liposomes [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (March 2005). Etude pharmacocinétique d'un nouvel inhibiteur des MMPs (I-col 51) après administration orale et intraveineuse de soultions à base d'hydroxypropyl-b-cyclodextrine [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France.

Barillaro, V., Evrard, B., Delattre, L., & Piel, G. (2005). Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing. AAPS Journal, 7 (1), 149-E155. doi:10.1208/aapsj070116

Bertholet, P., Guéders, M., Dive, G., Albert, A., Barillaro, V., Perly, B., Cataldo, D., Piel, G., Delattre, L., & Evrard, B. (2005). The Effect of Cyclodextrins on the Aqueous Solubility of a New Mmp Inhibitor: Phase Solubility, 1 H-Nmr Spectroscopy and Molecular Modeling Studies, Preparation and Stability Study of Nebulizable Solutions. Journal of Pharmacy and Pharmaceutical Sciences, 8 (2), 164-175.

Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (2005). Evaluation of the pulmonary inflammation and bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins. In Journal of inclusion Phenomena and Macrocyclic Chesmistry.

Hoebeke, M., Bahri, M. A., Grammenos, A., & Piel, G. (2005). ESR evidence of cholesterol extraction from liposome and cell membrane induced by RAMEB [Paper presentation]. General Congress of the SFP and BPS, Lille, France.

Jaspart, S., Piel, G., Delattre, L., & Evrard, B. (January 2005). Solid Lipid Microparticles: Formulation, Preparation, Characterisation, Drug Release and Applications. Expert Opinion on Drug Delivery, 2 (1), 75-87. doi:10.1517/17425247.2.1.75

Barillaro, V., Bertholet, P., Henry de Hassonville, S., Ziemons, E., Evrard, B., Delattre, L., & Piel, G. (30 November 2004). Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, 7 (3), 378-388.

Henry de Hassonville, S., Chiap, P., Liégeois, J.-F., Evrard, B., Delattre, L., Crommen, J., Piel, G., & Hubert, P. (21 September 2004). Development and validation of a high-performance liquid chromatographic method for the determination of cyproterone acetate in human skin. Journal of Pharmaceutical and Biomedical Analysis, 36 (1), 133-143. doi:10.1016/j.jpba.2004.05.023

Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (May 2004). Evaluation of the pulmonary inflammation and the bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins [Paper presentation]. XII th International Cyclodextrin Symposium, Montpellier, France.

Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (May 2004). Effect of methylated-b-cyclodextrin on the skin and influence on cyproterone acetate percutaneous absorption [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France.

Piel, G., Boulmedarat, L., Bochot, A., Delattre, L., & Fattal, E. (May 2004). Influence of methyl-b-cyclodextrin on the relase kinetics of inulin encapsulated in bioadhesive liposomes [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France.

Evrard, B., Bertholet, P., Guéders, M., Flament, M. P., Piel, G., Delattre, L., Gayot, A., Leterme, P., Foidart, J.-M., & Cataldo, D. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96 (3), 403-410. doi:10.1016/j.jconrel.2004.02.010

Hambach, L., Bahri, M. A., Piel, G., & Hoebeke, M. (2004). ESR quantification of DMPC liposome viscosity change by the addition of cholesterol and/or cyclodextrin [Paper presentation]. 12th meeting of the Benelux EPR Society, Antwerp, Belgium.

Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2004). La Rameb, un promoteur d’absorption cutanée pour l’acétate de cypro-térone ? [Paper presentation]. 7e journées du club cyclodextrines, Lille, France.

Henry de Hassonville, S., Dive, G., Evrard, B., Barillaro, V., Bertholet, P., Delattre, L., & Piel, G. (2004). Application of molecular modeling to the study of cyproterone acetate stability in the presence of cyclodextrin derivatives. Journal of Drug Delivery Science and Technology, 14 (5, SEP-OCT), 357-362. doi:10.1016/s1773-2247(04)50064-3

Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (January 2004). Etude des interactions cyclodextrines-liposomes: modification de la cinétique de libération de l'inuline encapsulée dans des lioposomes bioadhésifs en présence de méthyl-b-cyclodextrine [Paper presentation]. 7èmes Journées du Club français des Cyclodextrines, Lille, France.

Piel, G., Moutard, S., Perly, B., Henry de Hassonville, S., Bertholet, P., Barillaro, V., Piette, M., Delattre, L., & Evrard, B. (2004). Comparison of two methods currently used to determine the interaction between cyclodextrins and drugs: phase solubility diagrams and NMR spectroscopy. Journal of Drug Delivery Science and Technology, 14 (1, JAN-FEB), 87-91. doi:10.1016/s1773-2247(04)50010-2

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (2004). Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. European Journal of Pharmaceutics and Biopharmaceutics, 57 (3), 479-82. doi:10.1016/j.ejpb.2003.12.004

Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (12 November 2003). Influence de la methyl-b-cyclodextrine sur la cinetique de libération de l'inuline encapsulée dans des liposomes bioadhésifs [Poster presentation]. 18ème Journée Scientifique du GTRV, Lille, France.

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (October 2003). The skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Poster presentation]. Skin and Formulation, 1st Symposium, Paris, France.

Roland, I., Piel, G., Delattre, L., & Evrard, B. (16 September 2003). Systematic characterization of oil-in-water emulsions for formulation design. International Journal of Pharmaceutics, 263 (1-2), 85-94. doi:10.1016/S0378-5173(03)00364-8

Bertholet, P., Cataldo, D., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., & Evrard, B. (May 2003). Effect of inhaled cyclodextrins on the pulmonary inflammation and bronchial hyperresponsiveness in mice [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Bertolla, C., Piette, M., Evrard, B., Delattre, L., Piel, G., Frédérick, R., & Masereel, B. (May 2003). Synthèse de b-cyclodextrines modifiées [Poster presentation]. 17th Journées Franco-belges de Pharmacochimie, Bruxelles, Belgium.

Henry de Hassonville, S., Dive, G., Prosperi, C., Perly, B., Piel, G., Barillaro, V., Bertholet, P., Delattre, L., Llabres, G., & Evrard, B. (May 2003). Influence of cyclodextrins on the solubility and the stability of cyproterone acetate [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (May 2003). An ex-vivo study of the skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Roland, I., Piel, G., Delattre, L., & Evrard, B. (May 2003). Systematic characterization of oil-in-water emulsion for formulation design [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Barillaro, V., Van Hees, T., Bertini, S., Piel, G., Bertholet, P., Henry de Hassonville, S., Evrard, B., & Delattre, L. (January 2003). Etude de l'inclusion du miconazole dans les cyclodextrines par le CO2 supercritique: caracterisation des complexes par HPLC, CP-MAS-NMR et FT-IR [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France.

Bertholet, P., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (January 2003). Etude de l'hyperactivité bronchique induite par l'administration pulmonaire de cyclodextrines chez la souris [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France.

Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2003). Cyclodextrins as topical permeation enhancers : in vitro and in vivo testing [Poster presentation]. Symposium skin and formulation APGI, Paris, France.

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (January 2003). Etude comparative de la tolérance cutanée de nouveaux dérivés amphiphiles de cyclodextrines: les phospholipidyl-cyclodextines [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France.

Evrard, B., Chiap, P., De Tullio, P., Ghalmi, F., Piel, G., Van Hees, T., Crommen, J., Losson, B., & Delattre, L. (13 December 2002). Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin. Journal of Controlled Release, 85 (1-3), 45-50. doi:10.1016/S0168-3659(02)00270-5

Van Hees, T., Barillaro, V., Piel, G., Bertholet, P., De Hassonville, S., Evrard, B., & Delattre, L. (December 2002). Application of Supercritical carbon dioxide for the preparation of drug-cyclodextrin inclusion compounds. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44 (1-4), 271-274. doi:10.1023/A:1023084617964

Van Hees, T., Piel, G., Henry de Hassonville, S., Evrard, B., & Delattre, L. (May 2002). Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry. European Journal of Pharmaceutical Sciences, 15 (4), 347-353. doi:10.1016/S0928-0987(02)00018-0

Piel, G., Moutard, S., Van Hees, T., Henry de Hassonville, S., Delattre, L., & Evrard, B. (April 2002). Determination of the interaction between cyclodextins and drugs: comparison of two methods (phase solubility diagrams and NMR) [Poster presentation]. 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Firenze, Italy.

Barillaro, V., Van Hees, T., Piel, G., Henry de Hassonville, S., Bertholet, P., Evrard, B., & Delattre, L. (February 2002). Influence de l'ajout d'un composé ternaire dans la formation d'un complexe d'inclusion de miconazole dans les cyclodextrines par CO2 supercritique [Paper presentation]. 5ème Journée du Club français des Cyclodextrines, Amiens, France.

Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Barillaro, V., Betholet, P., Evrard, B., & Delattre, L. (February 2002). Augmentation de la solubilité de l'acétate de cyprotérone par formation de complexes d'inclusion dans les cyclodextrines [Paper presentation]. 5èmes Journées du Club français des Cyclodextrines, Amiens, France.

Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Delattre, L., & Evrard, B. (2002). Inclusion Complexes of Cyproterone Acetate with Cyclodextrins in Aqueous Solution. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44, 289-292. doi:10.1023/A:1023099611604

Piel, G., Hayette, M.-P., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., De Mol, P., & Delattre, L. (July 2001). In Vitro Comparison of the Antimycotic Activity of a Miconazole-Hp-Beta-Cyclodextrin Solution with a Miconazole Surfactant Solution. Journal of Antimicrobial Chemotherapy, 48 (1), 83-7. doi:10.1093/jac/48.1.83

Piel, G., Dive, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (June 2001). Molecular Modeling Study of Beta- and Gamma-Cyclodextrin Complexes with Miconazole. European Journal of Pharmaceutical Sciences, 13 (3), 271-9. doi:10.1016/S0928-0987(01)00113-0

Piel, G. (March 2001). Les formes galéniques destinées à la sphère ORL: composition et formulation [Paper presentation]. 55ème Journée d'Enseignement Post-Universitaire, Liège, Belgium.

Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Delattre, L., & Evrard, B. (2001). Preparation of mebendazole HP-beta-cyclodextrin complexes using water-soluble polymers and organic acids. STP Pharma Sciences, 11 (6), 439-442.

Alvarez, C, Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J.J, & Delattre, L. (2001). Préparation de complexes mebendazole-HPβCD à l'aide de polymères solubles dans l'eau et d'acides organiques. Annales Pharmaceutiques Françaises, 59, 380.

Ebo, D. G., Piel, G., Conraads, V., & Stevens, W. J. (2001). IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine. Annals of Allergy, Asthma and Immunology, 87 (3), 243-5. doi:10.1016/S1081-1206(10)62234-X

Piel, G., Llabres, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (2001). A nuclear magnetic resonance study of the miconazole-b-cyclodextrin inclusion complex in an acidic medium: determination of the structure and stability constants. STP Pharma Sciences, 11 (3), 235-238.

Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (December 2000). Préparation de complexes mébendazole-HPbCD à l'aide de polymères solubles dans l'eau et d'acides organiques [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France.

Piel, G., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (December 2000). Etude comparative de l'effet de différents acides et de différentes cyclodextrines sur la solubilité du miconazole, du kétoconazole et de l'itraconazole [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France.

Van Hees, T., Piel, G., Evrard, B., Henry de Hassonville, S., & Delattre, L. (December 2000). Solubility of p-hydroxybenzoic esters in supercritical carbon dioxide [Poster presentation]. 7th Meeting on Supercritical Fluids, Antibes, France.

Piel, G., Evrard, B., Van Hees, T., Hayette, M.-P., De Mol, P., & Delattre, L. (May 2000). Development of a new parenteral solution of miconazole by the use of cyclodextrins derivatives [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States.

Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (May 2000). Development of a cutaneous hydrogel containing miconazole by the useof hydroxypropyl-b-cyclodextrin and lactic acid [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States.

Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (April 2000). Preparation of mebendazole HP-b-cyclodextrin complexes using water soluble polymers and organic acids [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (April 2000). Development of a cutaneous hydrogel containing miconazole hydroxypropyl-b-cyclodextrin and lactic acid: study of its tolerability and efficacy [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Piel, G. (2000). Etude de l’interaction entre les cyclodextrines et le miconazole: application au développement d’une solution injectable et d’un gel cutané [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/34433

Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (2000). Inclusion of Piroxicam into Beta-Cyclodextrin by Means of Supercritical Carbon Dioxide: Thermal, Spectroscopic and Physicochemical Studies. Journal de Pharmacie de Belgique, 55 (1, Jan-Feb), 30-1.

Van Hees, T., Piel, G., Evrard, B., Otte, X., Thunus, L., & Delattre, L. (December 1999). Application of Supercritical Carbon Dioxide for the Preparation of a Piroxicam-Beta-Cyclodextrin Inclusion Compound. Pharmaceutical Research, 16 (12), 1864-70. doi:10.1023/A:1018955410414

Piel, G. (November 1999). Développement d'un gel cutané à base d'un complexe miconazole-HP-bCD: étude de sa tolérance et de son efficacité [Paper presentation]. 3èmes Journées du Club français des Cyclodextrines, Liège, Belgium.

Gabelica, V., Piel, G., Baykut, G., Jertz, R., & De Pauw, E. (June 1999). Study of cyclodextrin + drug systems in acidic aqueous soltuion by electrospray ionization F.T. mass spectroscopy [Poster presentation]. 3e MS Pharmaday Massa, Sienna, Italy.

Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (May 1999). A comparative study of the antimycotic activity of a miconazole-HP-b-CD solution to a surfactant solution [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (May 1999). Inclusion of piroxicam into b-cyclodextrin by means of supercritical carbon dioxide: thermal, spectroscopic and physicochemical studies [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences.

Piel, G., Evrard, B., Van Hees, T., & Delattre, L. (25 March 1999). Comparison of the Iv Pharmacokinetics in Sheep of Miconazole-Cyclodextrin Solutions and a Micellar Solution. International Journal of Pharmaceutics, 180 (1), 41-5. doi:10.1016/S0378-5173(98)00403-7

Evrard, B., De Tullio, P., Chiap, P., Van Hees, T., Piel, G., Crommen, J., Losson, B., & Delattre, L. (1999). The effect of hydroxypropyl-b-cyclodextrins on the pharamacokinetics of albendazole in sheep. In Proceedings of 26th International Symposium on Controlled Release of Bioactive Materials.

Piel, G., Evrard, B., Van Hees, T., Llabres, G., & Delattre, L. (1999). Development of a parenteral and of an oral formulation of albendazole with cyclodextrins. STP Pharma Sciences, 3, 257-260.

Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (1999). A Comparative Study of the Antimycotic Activity of a Miconazole Hp-Beta Cyclodextrin Solution and a Surfactant Solution. Journal de Pharmacie de Belgique, 54 (3, May-Jun), 87-8.

Evrard, B., Chiap, P., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Influence of cyclodextrins on the solubility and the pharmacokinetics of albendazole [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Evrard, B., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Development and pharmacokinetic evaluation of an oral liquid formulation of albendazole with cyclodextrins [Poster presentation]. 2th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France.

Piel, G., Evrard, B., Fillet, M., Llabres, G., & Delattre, L. (1998). Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. International Journal of Pharmaceutics, 169, 15-22. doi:10.1016/S0378-5173(98)00103-3

Piel, G., Evrard, B., Van Hees, T., Fernandez del Pozo, C., & Delattre, L. (1998). Development of a sustained release dosage form diclofenac-cyclodextrin inclusion complex [Poster presentation]. IX th International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Piel, G., Llabres, G., Fillet, M., Evrard, B., Van Hees, T., & Delattre, L. (1998). A proton nuclear resonance study of the inclusion complex of miconazole with b-cyclodextrin in an acidic medium [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France.

Piel, G., Van Hees, T., Evrard, B., & Delattre, L. (1998). A comparative pharmacokinetic study of intravenous solutions containig miconazole with or without cyclodextrins [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (1998). A comparative study of the dissolution properties of piroxicam-b-cyclodextrin inclusion complexes prepared by different methods [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (1998). Preparation of a drug-b-cyclodextrin inclusion compound using supercritical carbon dioxide [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France.

Evrard, B., Piel, G., Ceccato, A., & Delattre, L. (July 1997). Effects of cyclodextrins on the solubility characteristics of albendazole [Poster presentation]. Pharmaceutical appplication of Cyclodextrins Conference, Lawrence, Kansas, United States.

Piel, G., Evrard, B., & Delattre, L. (July 1997). Study of the combined effects of cyclodextrins and buffer type on the solubility of miconazole [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States.

Piel, G., Fillet, M., Evrard, B., Crommen, J., & Delattre, L. (July 1997). Comparison of the binding constant values of complexes of different antimycotic imidazole derivatives with cyclodextrin obtained by capillary electrophoresis and phase solubility diagram [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States.

Piel, G., Evrard, B., & Delattre, L. (April 1997). Multicomponent complexes of miconazole with different acids and cyclodextrins [Paper presentation]. VIIth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Piel, G., Pirotte, B., Delneuville, I., Neven, P., Llabres, G., Delarge, J., & Delattre, L. (April 1997). Study of the Influence of Both Cyclodextrins and L-Lysine on the Aqueous Solubility of Nimesulide; Isolation and Characterization of Nimesulide-L-Lysine-Cyclodextrin Complexes. Journal of Pharmaceutical Sciences, 86 (4), 475-80. doi:10.1021/js960298k

Piel, G., Evrard, B., & Delattre, L. (1997). Complexes à multicomposants de miconazole avec différents acides et cyclodextrines. Journal de Pharmacie de Belgique, 52 (3), 124.

Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (May 1996). Nimesulide-L-lysine-β- and γ-cyclodextrin complexes: preparation and dissolution properties [Paper presentation]. 6ème Forum des Sciences Pharmaceutiques, Blankenberge, Belgium.

Piel, G., Delneuville, I., & Delattre, L. (April 1996). In vitro and in vivo studies on sodium nimesulide-b-cyclodextrin inclusion complexes [Poster presentation]. VIIIth International Cyclodextrin Symposium, Budapest, Hungary.

Piel, G., Pochet, L., Delattre, L., & Delarge, J. (April 1996). Study of the influence of g-cyclodextrin on the molsidomine photostability [Poster presentation]. VIIIth International Cyclodextrin Symposium, Budapest, Hungary.

Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (February 1996). Preparation by spray drying of b and g-cyclodextrin inclusion complexes of a poorly soluble non steroidal anti-inflammatory drug [Poster presentation]. Formulation of Poorly-Available Drugs for Oral Administration, European Symposium, Paris, France.

Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (1996). Nimesulide-L-lysine-β- and γ-cyclodextrin complexes: preparation and dissolution properties. Journal de Pharmacie de Belgique, 51, 117.

Pirotte, B., Piel, G., Delneuville, I., Neven, P., & Geczy, J. (21 December 1995). WATER-SOLUBLE NIMESULIDE SALT, AND USES THEREOF FOR THE TREATMENT OF INFLAMMATIONS.

Piel, G., Pochet, L., Delattre, L., & Delarge, J. (June 1995). Photostability studies of molsidomine-cyclodextrin complexes [Poster presentation]. Photostability of drugs, 1st International Meeting, Oslo, Norway.

Piel, G. (1994). Etude de complexes d'inclusion nimésulide Na-cyclodextrines: fabrication, propriétés physico-chimiques et développement galénique [Specialised master, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/34431